| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |